STING1 and cancer: We will also focus on the important regulating roles of the cGAS–STING signaling pathway under pathological conditions, such as infections, cancers, autoimmune diseases, neurological diseases, and visceral inflammations, and review the progress in drug development targeting the cGAS–STING signaling pathway.